3 Reasons Well Health Technologies Is 1 of the Best Growth Stocks to Buy

There are tonnes of high-quality growth stocks to buy now, but, without a doubt, WELL Health Technologies has to be one of the very best.

| More on:
healthcare pharma

Image source: Getty Images

As many investors know, given that the market has been selling off consistently all year, there are plenty of quality stocks to buy today. Several of the best companies in Canada with significant long-term growth potential, such as WELL Health Technologies (TSX:WELL), are some of the best growth stocks you can buy, especially as they fall in price.

WELL isn’t the only stock to consider. There are tonnes of other options for investors. However, the healthcare tech stock is certainly among the top candidates, especially if you’re looking for a growth stock with years of opportunity to expand its operations.

If you’ve been considering WELL Health as it falls in price, or you’re just looking for one of the best growth stocks to buy now, here’s why WELL should be near the top of your buy list.

well health technologies best growth stocks buy

Healthcare is a defensive industry

As its name suggests, WELL Health Technologies is a tech stock. And as we’ve seen all year, tech stocks have been some of the hardest-hit stocks due to their sky-high valuations before the selloff and the fact that these stocks typically come with more risk.

With that being said, though, WELL’s entire business model is about supporting the healthcare industry. And healthcare is one of the most defensive industries.

So, the fact that WELL is a tech stock allows investors to buy it cheaply. However, because it operates in a defensive industry, it has the potential to continue growing its business even if the economy’s growth might be slowing down. And so far, that’s exactly what we’ve been seeing, showing that WELL Health is one of the best growth stocks to buy at this price.

WELL Health continues to fire on all cylinders

Last week, WELL provided another business update, and, as usual, the company continues to post impressive growth.

WELL reported a 40% year-over-year increase in omnichannel patient visits. It also continued to show strong and profitable growth in two of its largest subsidiary businesses, Circle Medical and WISP, with preliminary May results indicating a combined annual run rate of more than $110 million, which would be more than 150% growth year over year.

Another one of its most recent acquisitions, CognisantMD, is supporting roughly 45,000 monthly patient referrals and consults, which is already up roughly 30% from when it was acquired in December 2021.

Most importantly, though, WELL maintained its guidance for 2022. That means the company is still expecting to earn around $525 million in revenue and roughly $100 million in adjusted EBITDA. If you’re looking for high-quality and reliable growth stocks that continue to perform effectively, WELL is one of the best to buy now.

WELL Health stock is one of the best stocks to buy while it’s ultra cheap

WELL Health stock has been cheap for some time. However, recently, its continued selloff has made the stock extremely cheap.

With WELL stock trading at roughly $3.60 a share, the healthcare tech stock has a forward enterprise value (EV) to sales ratio of just 2.3 times. Even its EV-to-EBITDA ratio of just 12 times is cheap for a rapidly growing tech stock, which is expected to grow its EBITDA at a 15% compounded annual growth rate over the next two years.

Therefore, while this high-potential tech stock is trading well undervalued, it’s easily one of the best growth stocks you can buy now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has positions in WELL Health Technologies Corp. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

Woman has an idea
Tech Stocks

Prediction: 1 Stock That Could Trounce the Market 

The TSX has been favouring tech stocks, but not this one. However, it has the potential to trounce the market…

Read more »

clock time
Tech Stocks

Long-Term Investing: 3 Top Canadian Stocks You Can Buy for Under $20 a Share

These three under-$20 stocks offer excellent buying opportunities for long-term investors.

Read more »

Businessman holding AI cloud
Tech Stocks

AI Will Transform Everything: Investors, Be Early Adopters and Buy These 3 Stocks

Investors looking to invest in companies doing big things in AI should consider these three stocks for their portfolios.

Read more »

stock research, analyze data
Tech Stocks

Forget Shopify: These Unstoppable Stocks Are Better Buys Today 

Should you consider buying Shopify stock while rivals consider a buyout or should you go for stocks with a stronger…

Read more »

A colourful firework display
Tech Stocks

2 Potentially Explosive Stocks to Buy in March

These two growth stocks are destined for many more years of market-crushing returns.

Read more »

edit CRA taxes
Tech Stocks

TFSA Millionaires Are Learning They Can Still Be Taxed

If you day trade stocks like Shopify (TSX:SHOP) in a TFSA, you may be taxed.

Read more »

Shopping and e-commerce
Tech Stocks

Where Will Lightspeed Stock Be in 5 Years?

Lightspeed stock (TSX:LSPD) continues to be touch and go, so what might happen in the next five years?

Read more »

Technology
Tech Stocks

Here’s Why Constellation Software Is a No-Brainer Tech Stock

Are you looking for tech stocks to add to your portfolio? Constellation Software is a no-brainer!

Read more »